Cutter & Co Brokerage’s Biogen BIIB Stock Holding History

Cutter & Co Brokerage’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-596	Closed	-$211K	–	269
2018 Q3	$211K	Buy	+596	New	+$205K	0.07%	244

Other funds holding BIIB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Cutter & Co Brokerage's BIIB Position: Q4 2018 in Review

Cutter & Co Brokerage sold out of Biogen (BIIB) in Q4 2018, closing a stake of 596 shares — an estimated $211K sold.

Cutter & Co Brokerage first reported a position in BIIB in Q3 2018 and held it in 1 quarter. The position peaked at $211K in Q3 2018. 1,140 funds tracked by Wall St. Rank hold BIIB as of Q4 2018.

Cutter & Co Brokerage reported no remaining Biogen position as of Q4 2018 after selling out during the quarter.
Cutter & Co Brokerage sold 596 Biogen shares in Q4 2018, an estimated $211K.
Cutter & Co Brokerage first reported a position in Biogen in Q3 2018 and held it in 1 quarter.
Cutter & Co Brokerage's Biogen position peaked at $211K in Q3 2018.
1,140 funds tracked by Wall St. Rank held Biogen as of Q4 2018.

Based on Cutter & Co Brokerage's 13F filing for Q4 2018, filed 7 Feb 2019.